Medifast (NYSE:MED – Get Rating) had its price objective hoisted by investment analysts at DA Davidson from $71.00 to $75.00 in a note issued to investors on Thursday, The Fly reports. DA Davidson’s target price points to a potential downside of 11.69% from the stock’s previous close. Separately, StockNews.com upgraded shares of Medifast from a […]
Medifast (NYSE:MED – Get Rating) is one of 10 publicly-traded companies in the “Miscellaneous food preparations & kindred products” industry, but how does it compare to its competitors? We will compare Medifast to similar businesses based on the strength of its earnings, risk, institutional ownership, analyst recommendations, profitability, dividends and valuation. Earnings & Valuation This […]
Chickasaw Capital Management LLC lowered its position in shares of Medifast, Inc. (NYSE:MED – Get Rating) by 3.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,248 shares of the specialty retailer’s stock after selling 1,100 shares during […]
Medifast (NYSE:MED – Get Rating) and Wag! Group (NASDAQ:PET – Get Rating) are both small-cap consumer cyclical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership and profitability. Analyst Ratings This is a summary of recent ratings […]
Medifast (NYSE:MED – Get Rating) is one of 58 publicly-traded companies in the “Personal Services” industry, but how does it contrast to its peers? We will compare Medifast to similar businesses based on the strength of its profitability, institutional ownership, analyst recommendations, valuation, risk, dividends and earnings. Risk and Volatility Medifast has a beta of […]